FBRX
Forte Biosciences·NASDAQ
--
--(--)
--
--(--)
FBRX fundamentals
Forte Biosciences (FBRX) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.96 (YoY +85.78%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.96
+85.78%
Report date
Aug 14, 2025
Earnings Call
8:00 AM on Aug 13, 2025
Meeting link.EPS
Actual | -161.25 | -238 | -11.25 | -9 | -13.5 | -4.25 | -5.25 | -4.5 | -6 | -8 | -10.5 | -6.5 | 0 | -4 | -6.75 | -4.54 | 3.12 | -1.37 | -0.96 | ||||||||||
Forecast | -165 | -4.5 | -11.0833 | -11.5919 | -8.875 | -1.75 | -4.25 | -4.25 | -3.75 | -4 | -14.25 | -7 | -3.5 | -3.9375 | -6.3333 | -1.9925 | -0.95 | -1.1075 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +2.27% | -5188.89% | -1.50% | +22.36% | -52.11% | 0.00% | 0.00% | -23.53% | -20.00% | -50.00% | 0.00% | 0.00% | +54.39% | +100.00% | -14.29% | -71.43% | +28.32% | +256.59% | -44.21% | +13.32% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | -- | -- | 0 | 0 | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Forte Biosciences's gross profit margin?What does Forte Biosciences do and what are its main business segments?What is the market's earnings forecast for Forte Biosciences next quarter?What is the revenue and EPS growth rate for Forte Biosciences year over year?What were the key takeaways from Forte Biosciences's earnings call?Did Forte Biosciences beat or miss consensus estimates last quarter?What guidance did Forte Biosciences's management provide for the next earnings period?What is Forte Biosciences's latest dividend and current dividend yield?
